News
U.S. stocks closed rallied on Friday, with the Nasdaq Composite (COMP:IND) securing another back-to-back record, even as ...
3h
Fashion Glamp on MSNA Pivotal Advance in Obesity Treatment: Eli Lilly's Oral Pill Shows Significant Weight Loss in Landmark TrialA transformative moment in the global fight against obesity has emerged with the announcement of positive topline results ...
A legacy ranch in Jackson Hole, WY, has come onto the market, with records showing it is owned by former Eli Lilly exec Dr. Jan Lundberg.
An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...
Lupin introduces generic Glucagon for Injection USP in the US market. Bioequivalent to Eli Lilly's, used for hypoglycemia ...
Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.
Global pharma major Lupin Limited (Lupin) announced the launch of glucagon for injection USP, 1mg/vial packaged in an emergency kit in the United States. Glucagon for injection USP, 1mg/vial packaged ...
China’s drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...
7h
ThePrint on MSNBlockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunityPharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...
There's been an all-out push by the drug regulators and media to get every adult and child on Ozempic, a drug which causes temporary weight loss and harms the majority of recipients. Here, two leading ...
The drug category has an estimated annual sale of $122 million in the US. Shares of Lupin were marginally higher in the ...
There has been a 27% YoY increase in sales of weight-loss drugs, especially after the launch of Mounjaro and Novo Nordisk's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results